Project Grant D43TW013000
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $188,237 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Virginia (UVA) to train the next generation of epilepsy researchers. The goal of the 5-year Epilepsy Training Program (ETP) at UVA is to provide comprehensive training in the basic, translational, and clinical aspects of epilepsy research. The ETP will offer an epilepsy topics...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $512,438 to Vanderbilt University Medical Center (VUMC) on September 16, 2025 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, titled "Scaling Up Task-Shifted Epilepsy Care (SHIFT)," aims to integrate task-shifted epilepsy care and malnutrition care in five communities with populations over 100,000 people. The project...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $737,881 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Regents of the University of California, San Francisco (UCSF) to conduct secondary analyses of the ACTG IMAGINE-TBM clinical trial. The objectives are to use metagenomics and host transcriptomics to improve diagnosis of tuberculous meningitis (TBM) and assess treatment response in this...
- This $248,832 planning grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), which administers the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports the "Planning for Epilepsy Health Disparities Research Through Community Co-Production" project led by the Epilepsy Foundation of America. The project aims to study the drivers of health disparities in epilepsy and develop plans for...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $222,160 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of California, San Diego (UCSD). The grant will support Dr. Alena Stasenko's research to develop risk and resilience models of cognitive aging in epilepsy and novel, tech-based interventions to improve brain health. The project aims to leverage digital assessment to determine the...
- This federal Cooperative Agreement award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program, provides $3,940,692.87 to conduct a Phase 3 clinical trial of an e-health behavioral intervention to improve executive functioning in adolescents with epilepsy. The award recipient, Children's Hospital Medical Center, will evaluate a comprehensive e-health...
- This $207,002 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support the development of the Healthy Aging in People with Epilepsy Program (HAP-E), a community-informed, group-based educational program for older adults living with epilepsy. The key objectives are to: 1) determine stakeholders' needs, preferences, and barriers to accessing...
- This federal Project Grant award of $129,113 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the SPARQ: Summer Program to Advance Research and Equity in Pain and Neurological Health at Seattle Children's Hospital. The 9-week program aims to expose 10 undergraduate students per year to rigorous, interdisciplinary pain and neuroscience research, with a...
- This $1,309,206 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate spatial recognition memory processes in patients with epilepsy. The goal is to develop improved cognitive assessments and treatments for the memory deficits commonly experienced by epilepsy patients, which are not well captured by current neuropsychological...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $135,000 Project Grant titled "The NeuroCity Initiative: Empowering Underrepresented Scholars to Pursue Careers in Neuroscience" (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Rochester. This 5-year grant aims to provide an immersive research and mentoring experience, a rigorous career development program, and continuous research and mentoring...
TRAINING FOR RESEARCH EXCELLENCE IN NEUROLOGICAL NCDS AND DISORDERS IN ZAMBIA (TRENNDZ) - IN MAY 2022, THE WORLD HEALTH ORGANIZATION'S MEMBER STATES APPROVED AN INTERSECTORAL GLOBAL ACTION PLAN (IGAP) FOR EPILEPSY AND NEUROLOGICAL DISORDERS AIMED AT IMPROVING ACCESS TO CARE AND TREATMENTS FOR PERSONS WITH NEUROLOGICAL DISORDERS TOWARDS THE PROMOTION OF HEALTH ACROSS THE LIFESPAN. NEUROPSYCHIATRIC DISORDERS, WHICH INCLUDE NON-COMMUNICABLE DISEASES (NCDS) SUCH AS EPILEPSY AND STROKE, COMPRISE ONE-THIRD OF THE GLOBAL BURDEN OF DISEASE BASED UPON DISABILITY-ADJUSTED LIFE YEARS. ZAMBIA IS WELL-POSITIONED TO TAKE ON THE IGAP CHALLENGE. IN THE PAST DECADE, THANKS TO A SUCCESSFUL AND NOW SELF-SUSTAINING POST-GRADUATE CLINICAL TRAINING PROGRAM, ZAMBIA'S NEUROLOGICAL WORK FORCE HAS GROWN FROM A HANDFUL OF EXPATRIATE NEUROLOGISTS TO A STRONG, ZAMBIAN-LED ACADEMIC COMMUNITY PROVIDING CLINICAL SERVICES THROUGHOUT THE COUNTRY. IGAP IMPLEMENTATION IS CONSTRAINED, HOWEVER, BY CRITICAL DEFICITS IN OUR UNDERSTANDING OF THE PATHOPHYSIOLOGY, CLINICAL EPIDEMIOLOGY AND OPTIMAL MANAGEMENT STRATEGIES FOR NEURO-NCDS IN THE AFRICAN SETTING. ZAMBIAN CLINICIAN SCIENTISTS KEEN TO CONDUCT LOCAL, RELEVANT, HIGH-QUALITY RESEARCH IN NEURO-NCDS HAVE ALREADY BEGUN TO UNDERTAKE INVESTIGATIONS AIMED AT FILLING THESE GAPS. THE TRENNDZ (TRAINING IN RESEARCH EXCELLENCE IN NEUROLOGICAL NCDS AND DISORDERS IN ZAMBIA) D43 PROGRAM WILL PROVIDE THE PROFESSIONAL DEVELOPMENT OPPORTUNITIES NEEDED FOR THESE EMERGING INVESTIGATORS TO BECOME GLOBAL LEADERS IN NEURO-NCD RESEARCH, TO COMPETE SUCCESSFULLY FOR CAREER SUSTAINING AWARDS AND, EVENTUALLY, TO BECOME INDEPENDENT INVESTIGATORS AND MENTORS FOR THE NEXT GENERATION OF AFRICAN ACADEMICS. TO ACCOMPLISH THIS, TRENNDZ WILL PROVIDE A TRIPARTITE TRAINING PROGRAM. THE FOUNDATIONAL CORE WILL COMBINE ASYNCHRONOUS INSTRUCTION WITH IN-PERSON TRAINING USING A FLIPPED CLASSROOM APPROACH, WITH 15 MODULES OF TWO TO EIGHT WEEKS IN DURATION, TO PROVIDE A SOLID BACKGROUND ON RESEARCH METHODOLOGIES AS WELL AS PRACTICAL SKILLS NEEDED FOR ACADEMIC SUCCESS. THE CAPSTONE CORE WILL SUPPORT A ONE-YEAR, MENTORED, IN-COUNTRY RESEARCH FELLOWSHIP INCLUDING IN-PERSON, SMALL CLASSES ON GRANT WRITING, MANUSCRIPT PREPARATION AND OTHER CRITICAL ACADEMIC SKILLS. FINALLY, THROUGH A CUMULATIVE (ACROSS EVALUATED ACTIVITIES IN THE FOUNDATIONAL AND CAPSTONE CORES), COMPETITIVE PROCESS, THE ADVANCED CORE WILL SUPPORT A SUBSET OF D43 FELLOWS TO UNDERTAKE GRADUATE STUDIES AT THE UNIVERSITY OF ROCHESTER (UR) WHERE THEY WILL JOIN THE EXPERIMENTAL THERAPEUTICS IN NEUROLOGICAL DISEASE FELLOWS (T32NS007338-34) AND BENEFIT FROM BEING FULLY INTEGRATED INTO A PROGRAM OF US TRAINEES WITH SIMILAR INTERESTS AND EXPERTISE. SENIOR ZAMBIAN CONSULTANTS FROM PEDIATRICS, MEDICINE, AND NEUROPSYCHOLOGY WHOSE RESEARCH PROGRAMS INCLUDE NEURO-NCD INVESTIGATIONS AND NIH-FUNDED, US NEUROLOGISTS WITH DECADES OF EXPERIENCING WORKING IN ZAMBIA WILL SERVE AS THE IN-COUNTRY FACULTY WITH ADDITIONAL SUB-SPECIALTY OR METHODOLOGICAL EXPERTISE PROVIDED BY UR FACULTY, WHERE NEEDED, TO ASSURE ALL TRENNDZ FELLOWS HAVE THE FULL COMPLEMENT OF MENTORS NEEDED TO ASSURE THEIR SUCCESS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/12/25 | ||
| Not listed | $1.5k | 9/7/25 |